Synergy for Proteus meningitis

The phrase "Synergy for Proteus meningitis" is an administrative and pharmacotherapeutic concept rather than a standalone medical diagnosis, denoting the use of combination antimicrobial therapy to achieve enhanced bactericidal activity against central nervous system infections caused by *Proteus* species The underlying clinical condition, *Proteus* meningitis, is a severe, life-threatening infection of the leptomeninges and subarachnoid space primarily affecting neonates, immunocompromised indi...

The phrase "Synergy for Proteus meningitis" is an administrative and pharmacotherapeutic concept rather than a standalone medical diagnosis, denoting the use of combination antimicrobial therapy to achieve enhanced bactericidal activity against central nervous system infections caused by *Proteus* species In clinical pharmacology and treatment classifications, "synergy" refers to combining antimicrobial agents—classically a beta-lactam with an aminoglycoside—to overcome poor central nervous syst...

The underlying clinical condition, *Proteus* meningitis, is a severe, life-threatening infection of the leptomeninges and subarachnoid space primarily affecting neonates, immunocompromised individuals, or patients following neurosurgical interventions and head trauma

Pathophysiologically, it is characterized by acute purulent inflammation of the meninges, marked pleocytosis in the cerebrospinal fluid, and a notable propensity for necrotizing vasculitis, cerebral infarction, and brain abscess formation